Table 1.

Baseline characteristics and laboratory parameters of the patients.

Variables	Normal ascending aortic diameter (n = 99)	Dilated ascending aortic diameter (n = 85)	p value
Age, years	65.1 ± 9.6	65.9 ± 9.0	0.60
Sex (male), n (%)	67 (67)	54 (53)	0.55
BMI (kg/m2)	28.1 (5.1)	29.4 (6.1)	0.06
BSA (m2)	1.9 (0.2)	1.89 (0.2)	0.75
Hypertension, n (%)	61 (61)	62 (72)	0.10
Diabetes mellitus, n (%)	30 (30)	29 (34)	0.58
Smoking, n (%)	24 (24)	21 (24)	0.94
Glucose (mg/dL)	102 (28)	105 (59)	0.32
Total cholesterol (mg/dL)	188.8 ± 42.5	175.1 ± 48.1	0.04*
HDL (mg/dL)	43 (12.2)	40.9 (18.3)	0.01*
LDL (mg/dL)	112.5 ± 37.7	101.7 ± 37.6	0.05
Triglycerides (mg/dL)	138 (116)	126 (96)	0.49
Creatinine (mg/dL)	0.82 (0.28)	0.94 (0.41)	0.001*
GFR (mL/min/ m2)	88 (26)	77 (39)	<0.001*
Neutrophil (K/uL)	4370 (1800)	4450 (2620)	0.88
Lymphocyte (K/uL)	2260 ± 776	2094 ± 859	0.17
NLR	2.07 (1.35)	2.1 (2.25)	0.26
TSH (uIU/mL)	1.5 (1.5)	1.4 (1.3)	0.36
Native thiol (µmol/L)	439.2 ± 64.6	372.1 ± 73.9	<0.001*
Total thiol (µmol/L)	469.3 ± 64.1	403.1 ± 64.1	<0.001*
Disulphide (µmol/L)	16.2 (12.7)	15.3 (13.3)	0.23
Disulphide/Native thiol	0.04 (0.03)	0.04 (0.03)	0.79
Disulphide/Total thiol	0.03 (0.03)	0.04 (0.03)	0.80
Native thiol/Total thiol	0.93 (0.06)	0.92 (0.06)	0.86
Ferroxidase (U/L)	465 (186)	498(210)	0.12
IMA (ABSU)	75.7 ± 4.3	75.2 ± 5.9	0.53

BMI: Body mass index; BSA: Body surface area; GFR: Glomerular filtration rate; HDL: High-density lipoprotein; IMA: Ischemic modified albumin; IQR: Interquartile range; LDL: Llow-density lipoprotein; NLR: Neutrophil to lymphocyte ratio; SD: Standard deviation; TSH: Thyroid stimulating hormone. Parameters were expressed as mean ± SD and median [IQR].

*P < 0.05 was considered significant for statistical analyses.